These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4359661)

  • 1. [Drugs which influence plasma fatty acids and lipoproteins. Opinion of Prof. Rodolfo Paoletti].
    Salvati A
    Minerva Med; 1973 Sep; 64(62):3256-9. PubMed ID: 4359661
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone secretion in primary endogenous hypertriglyceridemia.
    Muggeo M; Fedele D; Tiengo A; Crepaldi G
    Horm Metab Res; 1973 May; 5(3):224-5. PubMed ID: 4714551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperlipiemia and its therapy by clofibrate].
    Nakano M; Nakamura Y
    Iryo; 1969 Dec; 23(12):1473-8. PubMed ID: 5381198
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of short-term use of clofibrate on the blood level of cholesterol, beta lipoproteins and free fatty acids].
    Modzelewski A; Zaczek-Modzelewska T
    Wiad Lek; 1970 Nov; 23(21):1937-9. PubMed ID: 5485649
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of hyperlipidemia].
    Müller G
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2020-4. PubMed ID: 4947270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypolipemic agents].
    Paoletti R; Fumagalli R; Sirtori R
    Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phospholipid fractions and free fatty acids in the serum of patients with hypertriglyceridemia treated with 1,5-dicaffeequinine acid].
    Wesołowska T; Szmatłoch E; Wira D; Pieczul-Mróz J; Gregorczyk J
    Przegl Lek; 1986; 43(7):527-30. PubMed ID: 3775065
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extra-adrenal lipolytic effect of an adrenocorticotropic pentacosapeptide: its influence on the free fatty acids in human plasma].
    Tragl KH; Pointner H; Geyer G
    Wien Klin Wochenschr; 1969 Sep; 81(39):680-4. PubMed ID: 4310113
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of growth hormone in primary dyslipidemias with hyperpre-beta-lipoproteinemia].
    Fedele D; Muggeo M; Bagnariol G; Fellin R; Tiengo A; Crepaldi G
    Folia Endocrinol; 1971; 24(5):352-68. PubMed ID: 5172224
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
    Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
    Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
    [No Abstract]   [Full Text] [Related]  

  • 13. Apolipoprotein B metabolism in dyslipidaemia and the effect of drugs.
    Packard CJ
    Diabetes Nutr Metab; 1999 Oct; 12(5):311-5. PubMed ID: 10741344
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 15. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 16. [Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits].
    Elsair J; Marquie G; Drif M; Khelfat K; Benouniche N; Tabet Aoul M; Tabet Aoul FS; Iklef F; Ghouini A
    C R Seances Soc Biol Fil; 1982; 176(2):140-5. PubMed ID: 6212098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipemic conditions: results of their treatment with clofibrate-methandrostenolone].
    Ciammaichella A; Torcia L
    Boll Soc Ital Cardiol; 1971; 16(12):841-51. PubMed ID: 5150179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.